Literature DB >> 23155135

Breast MRI use uncommon among U.S. women.

Jacqueline W Miller1, Susan A Sabatino, Trevor D Thompson, Nancy Breen, Mary C White, A Blythe Ryerson, Stephen Taplin, Rachel Ballard-Barbash.   

Abstract

BACKGROUND: The goal of breast cancer screening is to reduce breast cancer mortality. Mammography is the standard screening method for detecting breast cancer early. Breast MRI is recommended to be used in conjunction with mammography for screening subsets of women at high risk for breast cancer. We offer the first study to provide national estimates of breast MRI use among women in the United States.
METHODS: We analyzed data from women who responded to questions about having a breast MRI on the 2010 National Health Interview Survey. We assessed report of having a breast MRI and reasons for it by sociodemographic characteristics and access to health care and computed five-year and lifetime breast cancer risk using the Gail model.
RESULTS: Among 11,222 women who responded, almost 5% reported ever having a breast MRI and 2% reported having an MRI within the 2 years preceding the survey. Less than half of the women who reported having a breast MRI were at increased risk. Approximately 60% of women reported having the breast MRI for diagnostic reasons. Women who ever had a breast MRI were more likely to be older, Black, and insured and to report a usual source of health care as compared with women who reported no MRI.
CONCLUSIONS: Breast MRI use may be underused or overused in certain subgroups of women. IMPACT: As access to health care improves, the use of breast MRI and the appropriateness of its use for breast cancer detection will be important to monitor.

Entities:  

Mesh:

Year:  2012        PMID: 23155135      PMCID: PMC3538940          DOI: 10.1158/1055-9965.EPI-12-0967

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  22 in total

1.  Meta-analysis of MR imaging in the diagnosis of breast lesions.

Authors:  Nicky H G M Peters; Inne H M Borel Rinkes; Nicolaas P A Zuithoff; Willem P T M Mali; Karel G M Moons; Petra H M Peeters
Journal:  Radiology       Date:  2007-11-16       Impact factor: 11.105

2.  Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.

Authors:  Wendie A Berg; Zheng Zhang; Daniel Lehrer; Roberta A Jong; Etta D Pisano; Richard G Barr; Marcela Böhm-Vélez; Mary C Mahoney; W Phil Evans; Linda H Larsen; Marilyn J Morton; Ellen B Mendelson; Dione M Farria; Jean B Cormack; Helga S Marques; Amanda Adams; Nolin M Yeh; Glenna Gabrielli
Journal:  JAMA       Date:  2012-04-04       Impact factor: 56.272

3.  Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

Authors:  Andrew N Freedman; Barry I Graubard; Sowmya R Rao; Worta McCaskill-Stevens; Rachel Ballard-Barbash; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2003-04-02       Impact factor: 13.506

4.  Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screening.

Authors:  Barry I Graubard; Andrew N Freedman; Mitchell H Gail
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-09-14       Impact factor: 4.254

5.  Overdiagnosis in organised mammography screening in Denmark. A comparative study.

Authors:  Karsten J Jørgensen; Per-Henrik Zahl; Peter C Gøtzsche
Journal:  BMC Womens Health       Date:  2009-12-22       Impact factor: 2.809

Review 6.  Screening for breast cancer: an update for the U.S. Preventive Services Task Force.

Authors:  Heidi D Nelson; Kari Tyne; Arpana Naik; Christina Bougatsos; Benjamin K Chan; Linda Humphrey
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

7.  Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.

Authors:  Mieke Kriege; Cecile T M Brekelmans; Carla Boetes; Peter E Besnard; Harmine M Zonderland; Inge Marie Obdeijn; Radu A Manoliu; Theo Kok; Hans Peterse; Madeleine M A Tilanus-Linthorst; Sara H Muller; Sybren Meijer; Jan C Oosterwijk; Louk V A M Beex; Rob A E M Tollenaar; Harry J de Koning; Emiel J T Rutgers; Jan G M Klijn
Journal:  N Engl J Med       Date:  2004-07-29       Impact factor: 91.245

Review 8.  A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer.

Authors:  S J Lord; W Lei; P Craft; J N Cawson; I Morris; S Walleser; A Griffiths; S Parker; N Houssami
Journal:  Eur J Cancer       Date:  2007-08-02       Impact factor: 9.162

9.  Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: results from a national survey.

Authors:  Susan A Sabatino; Risa B Burns; Roger B Davis; Russell S Phillips; Ya-Hua Chen; Ellen P McCarthy
Journal:  Cancer       Date:  2004-06-01       Impact factor: 6.860

10.  Misclassification of survey responses and black-white disparity in mammography use, Behavioral Risk Factor Surveillance System, 1995-2006.

Authors:  Rashid Njai; Paul Z Siegel; Jacqueline W Miller; Youlian Liao
Journal:  Prev Chronic Dis       Date:  2011-04-15       Impact factor: 2.830

View more
  8 in total

1.  Informing Women and Their Physicians about Recommendations for Adjunct Breast MRI Screening: A Cohort Study.

Authors:  John T Brinton; Lora D Barke; Mary E Freivogel; Tiffany C Talley; Michelle D Lexin; Alicia L Drew; Rachel B Beam; Deborah H Glueck
Journal:  Health Commun       Date:  2017-02-03

2.  Factors associated with breast MRI use among women with a family history of breast cancer.

Authors:  Mary C White; Ashwini Soman; Clarice R Weinberg; Juan L Rodriguez; Susan A Sabatino; Lucy A Peipins; Lisa DeRoo; Hazel B Nichols; M Elizabeth Hodgson; Dale P Sandler
Journal:  Breast J       Date:  2018-05-20       Impact factor: 2.431

3.  Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status.

Authors:  Jennifer S Haas; Deirdre A Hill; Robert D Wellman; Rebecca A Hubbard; Christoph I Lee; Karen J Wernli; Natasha K Stout; Anna N A Tosteson; Louise M Henderson; Jennifer A Alford-Teaster; Tracy L Onega
Journal:  Cancer       Date:  2015-12-28       Impact factor: 6.860

4.  Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk.

Authors:  Randy Miles; Fei Wan; Tracy L Onega; Amanda Lenderink-Carpenter; Ellen S O'Meara; Weiwei Zhu; Louise M Henderson; Jennifer S Haas; Deirdre A Hill; Anna N A Tosteson; Karen J Wernli; Jennifer Alford-Teaster; Janie M Lee; Constance D Lehman; Christoph I Lee
Journal:  J Womens Health (Larchmt)       Date:  2018-01-17       Impact factor: 2.681

5.  Patterns of breast magnetic resonance imaging use in community practice.

Authors:  Karen J Wernli; Wendy B DeMartini; Laura Ichikawa; Constance D Lehman; Tracy Onega; Karla Kerlikowske; Louise M Henderson; Berta M Geller; Mike Hofmann; Bonnie C Yankaskas
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

6.  Rapid increase in breast magnetic resonance imaging use: trends from 2000 to 2011.

Authors:  Natasha K Stout; Larissa Nekhlyudov; Lingling Li; Elisabeth S Malin; Dennis Ross-Degnan; Diana S M Buist; Marjorie A Rosenberg; Marina Alfisher; Suzanne W Fletcher
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

7.  Recent Trends in Screening Breast MRI.

Authors:  Michelle V Lee; Shani Aharon; Kevin Kim; Katerina Sunn Konstantinoff; Catherine M Appleton; Dustin Stwalley; Margaret A Olsen
Journal:  J Breast Imaging       Date:  2021-12-11

8.  Population-Based Assessment of the Association Between Magnetic Resonance Imaging Background Parenchymal Enhancement and Future Primary Breast Cancer Risk.

Authors:  Vignesh A Arasu; Diana L Miglioretti; Brian L Sprague; Nila H Alsheik; Diana S M Buist; Louise M Henderson; Sally D Herschorn; Janie M Lee; Tracy Onega; Garth H Rauscher; Karen J Wernli; Constance D Lehman; Karla Kerlikowske
Journal:  J Clin Oncol       Date:  2019-01-09       Impact factor: 50.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.